Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice

Abstract

α-amylase inhibitors are an important class of second-line antihyperglycemic drugs. They slow down the breakdown and absorption of carbohydrates, reducing peak glucose concentration with meals. Recent reports have also shown other beneficial effects of α-amylase inhibitors on type 2 diabetes mellitus (T2DM)